The Top Beach Bod Stocks to Consider Now

April 19, 2023 www.tradewins.com Other Exciting News The Hidden Trigger Dear Trader, I predicted the crash of '08. I called out the collapse of Lehman Brothers, the UK economic disaster AND the Covid Crash. And I put my followers on Netflix back when it dipped to $10 a share. How did I nail so many financial predictions? Click Here to find out. Insider Reveals How He Uses "News Hacking" To Spot Major Moves Ian Cooper Recent Articles The Top Beach Bod Stocks to Consider Now by Ian Cooper Analyzing the Option’s Price by Rob Roy KeyPoint Market Daily by Joe Duffy Guaranteed Real Optioneering Winners by Chuck Hughes TradeWins Author Team     Unlock the 30-day secret to potentially making an extra $1,403 per month with a tiny account! In fact, You could’ve made a total of 742% on your money doing exactly this the past 5 years (includes winners and losers). What if you could make an extra $1,403 every 30 days? You’re not getting rich, per se… But you’re generating some extra cash to have and spend during these unprecedented economic times. Now, that $1,403 isn’t a promise… it’s simply an average. As you’re about to see… with many opportunities, you could’ve had months where you turned a few hundred bucks into thousands and thousands. You don’t need any special skills. Just patience and trust in a system that’s worked for years. My system. Join Trade Alert 365 Now For Just $1 About TradeWins Inside Trading Newsletter Webinars Videos Trading Strategy Options Futures Forex Day Trading Subscription Services E-Books Customer Satisfaction Survey 2020 The Top Beach Bod Stocks to Consider Now by Ian Cooper With summer just weeks away already, many of us are scrambling to get back into shape. So, we went hunting for some of the top stocks that could move as the weather warms up. One of the top ones is WW (WW), formerly Weight Watchers. Sure, the stock was severely beaten down on slowing growth, but its latest acquisition may have breathed new life into it. Its latest acquisition of Sequence could be a game-changer for WW International. In fact, DA Davidson analyst Linda Bolton Weiser has a buy rating on the WW stock with a $9 price target. The analyst noted: The company's acquisition of Sequence and ability to offer scripts for Wegovy is a "game-changer". Over 70% of WW members are obese and possible drug candidates, and if the company trades up just 10% of its obese North America subs to $99 monthly drug maintenance, it could add over 50% to North America sales. Even Goldman Sachs analyst Jason English just upgraded WW to a buy rating, with a price target of $13 from $3.80 a share. Better, with the acquisition, WW enters the prescription drug and clinical weight loss segment. In addition, Sequence clinicians can prescribe medications like Novo Nordisk's Wegovy and Saxenda, and Eli Lilly's Mounjaro.Currently, Wegovy and Saxenda are approved drugs for obesity in the United States, with tirzepatide also widely expected to be approved for it later this year, as noted by a Seeking Alpha article. Read More   Analyzing the Option’s Price by Rob Roy The bid and ask prices are known as the “natural” prices of the option. The bid price shows what the option may be sold at right now, while the ask price shows what the option may be bought at right now. To explain this, think of the bid price as the wholesale price, and the ask price as the retail price. It would be great to be able to buy options at the wholesale (bid) price and sell them at the retail (ask) price. However, the off-floor trader (anyone who does not work at an exchange), cannot do this. The bid and ask prices represent at what point the option can be bought and sold right now. Trading off these prices alone would be like going to a car dealer, and not negotiating price. If you walked into the car dealership you will see the “sticker” price on the car. No one pays the sticker price. Read More Joe Duffy’s KeyPoint Market Daily April 19, 2023 Elite Wall Street trader, Joe Duffy, is allowing a limited group of future-elite investors into his masterful daily trades at thousands of dollars less than what others charge. When you join today for $1, the first month you'll receive:   Joe Duffy’s daily video newsletter with updates on what's happening in the markets that very day. Rather than watch talking heads for hours on cable, I'll get you up to speed in minutes. You get weekend updates where I delve more into 'bigger picture' looks at the marketplace. Videos are illustrative, instructive, concise, and un-hedged. No double talk here. And much, much more! Check out his most recent video here: Guaranteed Real Optioneering Winners by Chuck Hughes The first profit opportunity we will review is in VIST, or Vista Oil & Gas, S.A.B. de C.V. VIST is engaged in the energy sector. It focuses on the identification, acquisition and development of oil and gas fields primarily in Mexico, Argentina, Brazil and Colombia. The monthly chart shows that VIST just hit a new record high. A new record high is a positive sign for the bulls. The daily chart shows that VIST has been moving steadily higher since the chart started in July. There are no signs of a peak in the movement. We recommend buying VIST stock at the current price level. Read More   www.tradewins.com                © Copyright 2023 TradeWins.com. All rights reserved. TradeWins Publishing, 22C New Leicester Hwy, #117, Asheville, NC 28806 Email: support@iss-trading.com   |   Phone: 888-233-1431   |   Fax: 888-258-4938   PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading. 1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis. 2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services. 3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber. 4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more. 5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities. 6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown. 7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses. 8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
TradeWins Publishing, 528 North Country Rd., St. James, NY 11780

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: